Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial of vinorelbine plus gemcitabine for platinum-resistant recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
This Phase 2 trial evaluates the combination of sorafenib and topotecan in patients with platinum-resistant recurrent ovarian cancer, report…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 study of intraperitoneal catumaxomab followed by chemotherapy shows feasibility and signs of clinical activity in patients with re…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 trial assessing gemcitabine and docetaxel in relapsed or refractory ovarian epithelial or peritoneal cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety, tolerability, and activity of lonafarnib in combination with docetaxel (Study P04467AM1) was terminated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update evaluating a PARP inhibitor for BRCA-positive advanced ovarian cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]
Phase 1 trial update evaluating PET/CT imaging with MK-0000-143 in relapsed ovarian cancer, primary peritoneal cancer, and fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer [Phase 3]
Phase 3 trial assessing nintedanib added to paclitaxel and carboplatin vs placebo in first-line treatment of ovarian cancer; results were po…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing ATI-0918 and liposomal doxorubicin (DOXIL/CAELYX) in patients with ovarian cancer, sponso…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Pharmacogenomics of Paclitaxel in Ovarian Cancer
This Clinical Trial Update documents the completion of a pharmacogenomics study evaluating how genetic variation influences paclitaxel treat…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Doxil and Gemcitabine in Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Doxil (liposomal doxorubicin) with gemcitabine in recurrent ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study [Phase 2]
Phase 2 trial update of vismodegib in patients previously treated with vismodegib, with the study status completed and results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) [Phase 2]
Phase 2 study evaluating Doxil and vintafolide for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) [Phase 2]
A Phase 2 study of vintafolide (MK-8109, EC145) in advanced ovarian and endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 evaluation of cisplatin plus paclitaxel in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Phase 1]
Phase 1 trial investigating carboplatin, paclitaxel, and pegfilgrastim in patients with Stage III/IV ovarian epithelial, fallopian tube, pri…
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 trial of Acetyl-L-Carnitine hydrochloride to prevent chemotherapy-induced peripheral neuropathy in patients with recurrent ovarian…
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating VTX-2337, a TLR8 agonist, in combination with pegylated liposoma…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with paclitaxel and carboplatin with or without sorafenib in ovarian cancer; the study complete…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]
Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2…
-
CLINICAL_TRIALS research · 2014-12-05Clinical Trial Update: Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
A clinical trial update examining short non-coding RNA biomarkers that may indicate predisposition to ovarian cancer. The study is sponsored…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer [Phase 2]
A randomized, placebo-controlled Phase II trial assessed continuous maintenance therapy with BIBF 1120 (nintedanib) after chemotherapy in re…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]
Phase 2 study evaluating pertuzumab in combination with carboplatin-based chemotherapy for recurrent ovarian cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Cabazitaxel in Platinum Refractory Ovarian Cancer [Phase 2]
A Phase 2 study of cabazitaxel in platinum-refractory ovarian cancer has been terminated.